NCT06533410 Using the Chinese Indigenization FS Scale in the Diagnosis of Fibromyalgia： Specificity and Sensitivity in Clinical Practice
| NCT ID | NCT06533410 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Guang'anmen Hospital of China Academy of Chinese Medical Sciences |
| Condition | Fibromyalgia |
| Study Type | OBSERVATIONAL |
| Enrollment | 59 participants |
| Start Date | 2024-05-21 |
| Primary Completion | 2025-03-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 59 participants in total. It began in 2024-05-21 with a primary completion date of 2025-03-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aimed to evaluate the specificity and sensitivity of the diagnostic criteria for fibromyalgia after conducting local validation in China.
Eligibility Criteria
Inclusion Criteria: * At least 18 years of age; Patients with chronic widespread pain; Able to complete the questionnaire. Exclusion Criteria: * Terminal patients with severe psychiatric diseases, tumors, systemic lupus erythematosus, systemic sclerosis, or other serious diseases.
Frequently Asked Questions
Who can join the NCT06533410 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Fibromyalgia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06533410 currently recruiting?
Yes, NCT06533410 is actively recruiting participants. Visit ClinicalTrials.gov or contact Guang'anmen Hospital of China Academy of Chinese Medical Sciences to inquire about joining.
Where is the NCT06533410 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT06533410 clinical trial?
NCT06533410 is sponsored by Guang'anmen Hospital of China Academy of Chinese Medical Sciences. The trial plans to enroll 59 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.